Gainers
- CNS Pharma CNSP shares rose 143.7% to $0.38 during Wednesday's pre-market session. The company's market cap stands at $12.2 million.
- DBV Technologies DBVT stock moved upwards by 62.87% to $1.14. The company's market cap stands at $109.6 million.
- Cyclacel Pharmaceuticals CYCC stock moved upwards by 46.15% to $2.09. The market value of their outstanding shares is at $4.1 million.
- Mustang Bio MBIO shares rose 34.59% to $0.38. The company's market cap stands at $14.1 million.
- LakeShore Biopharma LSB stock rose 25.49% to $3.2. The market value of their outstanding shares is at $61.0 million.
- BioVie BIVI stock increased by 19.34% to $4.01. The market value of their outstanding shares is at $32.0 million.
Losers
- Alto Neuroscience ANRO shares decreased by 62.3% to $5.48 during Wednesday's pre-market session. The market value of their outstanding shares is at $147.7 million.
- Ensysce Biosciences ENSC shares decreased by 18.58% to $0.44. The company's market cap stands at $6.0 million.
- Genprex GNPX stock decreased by 14.49% to $3.07. The company's market cap stands at $7.9 million.
- TELA Bio TELA shares fell 14.46% to $2.13. The company's market cap stands at $52.6 million.
- Aptevo Therapeutics APVO stock declined by 12.7% to $0.31. The company's market cap stands at $4.1 million.
- Creative Medical Tech CELZ stock declined by 11.51% to $4.0. The market value of their outstanding shares is at $5.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
APVOAptevo Therapeutics Inc
$4.776.95%
BIVIBioVie Inc
$2.18-2.68%
CELZCreative Medical Technology Holdings Inc
$2.06-9.25%
CNSPCNS Pharmaceuticals Inc
$0.10200.10%
CYCCCyclacel Pharmaceuticals Inc
$0.3499-1.69%
DBVTDBV Technologies SA
$4.693.30%
ENSCEnsysce Biosciences Inc
$7.77-%
GNPXGenprex Inc
$0.73462.03%
LSBLakeShore Biopharma Co Ltd
$2.29-15.9%
MBIOMustang Bio Inc
$5.590.72%
TELATELA Bio Inc
$3.1015.2%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in